PNEUMOCOCCAL INFECTIOUS DISEASE
Clinical trials for PNEUMOCOCCAL INFECTIOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTIOUS DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTIOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 24-Valent pneumococcal vaccine shows promise in kids
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine (PCV24) designed to protect children aged 2-17 against pneumococcal disease, which can cause pneumonia and meningitis. The trial involved 119 healthy children and checked for side effects and immune response. The vaccine aims to cover 24 strains of…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 11:05 UTC
-
New pneumonia vaccine shows promise in protecting little ones
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine (PCV13) designed to protect children from serious infections caused by pneumococcal bacteria, such as pneumonia and meningitis. The trial involved 140 healthy infants (2 months old) and children (2–5 years old) to check the vaccine's safety and how…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE1 • Sponsor: Sinovac Research and Development Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:04 UTC
-
New vaccine targets 24 pneumonia strains in adult trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine (PCV24) designed to protect against 24 types of pneumococcal bacteria, which can cause pneumonia and other infections. 385 healthy adults aged 18 and older received the vaccine to check its safety and how well it triggers the immune system. The tri…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:00 UTC